Shibo Li

Shibo Li


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2003 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
PDF file
SLShibo Li
Shibo Li
SHSusan Hassed
Susan Hassed
JMJohn J. Mulvihill
John J. Mulvihill
ANAmbika K. Nair
Ambika K. Nair
DHDeborah J. Hopcus
Deborah J. Hopcus
Click on the article title to read more.

25 July 2018 in JCI Insight
Verified
Journal Article
Open access
PDF file
YKYuji Kondo
Yuji Kondo
JFJianxin Fu
Jianxin Fu
HWHua Wang
Hua Wang
CHChristopher Michael Hoover
Christopher Michael Hoover
JMJ. Michael McDaniel
J. Michael McDaniel
LXLijun Xia
Lijun Xia
Site-1 protease (S1P), encoded by MBTPS1, is a serine protease in the Golgi. S1P regulates lipogenesis, endoplasmic reticulum (ER) function, and lysosome biogenesis in mice and in cultured cells. However, how S1P differentially regulates these diverse functions in humans has been unclear. In addition, no human disease with S1P deficiency has been identified. Here, we report a pediatric patient with an amorphic and a severely hypomorphic mutation in MBTPS1 . The unique combination of these mutations results in a frequency of functional MBTPS1 transcripts of approximately 1%, a finding that is associated with skeletal dysplasia and elevated blood lysosomal enzymes. We found that the residually expressed S1P is sufficient for lipid homeostasis but not for ER and lysosomal functions, especially in chondrocytes. The defective S1P function specifically impairs activation of the ER stress transducer BBF2H7, leading to ER retention of collagen in chondrocytes. S1P deficiency also causes abnormal secretion of lysosomal enzymes due to partial impairment of mannose-6-phosphate–dependent delivery to lysosomes. Collectively, these abnormalities lead to apoptosis of chondrocytes and lysosomal enzyme–mediated degradation of the bone matrix. Correction of an MBTPS1 variant or reduction of ER stress mitigated collagen-trafficking defects. These results define a new congenital human skeletal disorder and, more importantly, reveal that S1P is particularly required for skeletal development in humans. Our findings may also lead to new therapies for other genetic skeletal diseases, as ER dysfunction is common in these disorders.

23 June 2020 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
HPHui Pang
Hui Pang
XYXiaowei Yu
Xiaowei Yu
YKYoung Mi Kim
Young Mi Kim
XWXianfu Wang
Xianfu Wang
JJJeremy K. Jinkins
Jeremy K. Jinkins
HGHongcang Gu
Hongcang Gu
The subchromosomal region 1q21.1 is one of the hotspots in the human genome for deletions and reciprocal duplications, owing to the existence of hundreds of segmental duplications. Recurrent deletions and duplications in this region are thought to be causative in patients with variable clinical manifestations. Based on the genomic locations, deletions and duplications at the 1q21.1 locus have been associated with distinguishable syndromes: chromosome 1q21.1 deletion syndrome, chromosome 1q21.1 duplication syndrome, and thrombocytopenia-absent radius (TAR) syndrome, which is partially due to deletions at the proximal 1q21.1 region. We report here diverse, recurrent deletions and duplications at the 1q21.1 locus in 36 patients from a cohort of 5,200 individuals. Among the 36 patients, 18 patients carry 1q21.1 deletions, nine individuals have reciprocal duplications at 1q21.1, two patients share an identical short deletion, and the remaining seven possess variable sizes of duplications at the proximal 1q21.1 region. Furthermore, we provide cytogenetic characterization and detailed clinical features for each patient. Notably, duplications at the proximal 1q21.1 region have not been associated with a defined disorder in publications. However, recurrent duplications at the proximal 1q21.1 region among the seven patients strongly suggested that the variants are likely pathogenic. The common phenotypical features of those disorders are also summarized to facilitate clinical diagnoses and genetic counseling.

24 April 2014 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
WXWeihong Xu
Weihong Xu
XYXiao Yang
Xiao Yang
XHXiaoxia Hu
Xiaoxia Hu
SLShibo Li
Shibo Li
Neurofibromatosis type 1 (NF1) is a common autosomal dominant genetic disorder caused by mutations in the NF1 gene. One of the hallmarks of NF1 is the high mutation rate in this gene. In this study, we present 127 different NF1 mutations and 54 novel mutations detected at both the genomic DNA and mRNA level using a retrospective case series review. We found that 25.2% of these different mutations induced aberrant splicing. Of note, 40.6% of these splicing errors were caused by exonic variants. In addition, one mutation produced mosaicism in the post-transcriptional profile. However, studies investigating these splicing aberrations are limited. In order to better understand the pathogenicity of NF1 and to provide a more accurate interpretation in molecular diagnostic testing, combined computational analyses were employed to elucidate the underlying mechanisms of the variants modulating NF1 gene splicing.

24 September 2013 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
WZWei Zhao
Wei Zhao
GNGuannan Niu
Guannan Niu
BSBotao Shen
Botao Shen
YZYang Zheng
Yang Zheng
FGFangchao Gong
Fangchao Gong
SLShibo Li
Shibo Li

12 May 2011 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
HZHan Zhang
Han Zhang
XLXianglan Lu
Xianglan Lu
JBJulie Beasley
Julie Beasley
JMJohn J Mulvihill
John J Mulvihill
RLRuizhi Liu
Ruizhi Liu
JLJi-Yun Lee
Ji-Yun Lee